Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Philadelphia Personal Injury LawyerBristol-Myers Drug Videx Poses Liver Risk
By Jamie Sheller
Recently, the FDA issued a warning regarding the drug Videx, which is made by Bristol-Myers. Videx is an HIV drug, approved in 1991. The drug keeps HIV from multiplying. According to the FDA, Videx users are at risk for developing a rare, but potentially fatal liver disorder. The specific liver disorder is called non-cirrhotic portal hypertension. So far, 4 people of the 32 reported cases, have died from bleeding or liver failure. With non-cirrhotic portal hypertension, the blood flow through the liver is dangerously slow. This can cause swelling in the veins of the esophagus. If those veins burst, it can result in potentially deadly bleeding.
Videx is not being recalled, because the FDA believes that its benefits to patients outweigh its risks. However, new warnings are being added to the Videx label, describing the signs and symptoms of the liver disorder. The label warnings advise monitoring patients for early signs of non-cirrhotic portal hypertension.
If you have used Videx and developed non-cirrhotic portal hypertension, contact Sheller, P.C. Sheller is a leading pharmaceutical negligence firm. Sheller has a long history of successful representation of individuals and classes of individuals in lawsuits over various drugs, including Vioxx, Paxil, Fen Phen, Seroquel and Prozac, among others. Contact Sheller to discuss your potential legal claims.
Originally posted at InjuryBoard by Jamie Sheller
Full post as published by Philadelphia Personal Injury Lawyer on February 03, 2010 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Bextra Product Recall
Find a Bextra Lawyer
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Bristol-Myers Gets Preliminary Approval of $125 MillionPlavix Settlement
Bristol-Myers Gets Preliminary Approval of $125 MillionPlavix Settlement
Vytorin
alleged risk of heart attack and liver damage.
Transdermal Drug Patches
Risk of Burns Missing From Some Labeling
COPD Drug
allegedly increases risk of death from cardiovascular and respiratory events.
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Tarceva
Safety Data Show Association with Liver Failure and Death

FDA Warns that HIV Drug May Cause Liver Failure
Old HIV Drug Linked to Liver Problems
Former Bristol-Myers Exec Charged Over Secret Settlement
Pen-ance: Bristol-Myers Exec. Gets Two Years of Hard Writing
Bristol-Myers Squibb to Acquire Medarex
Bristol-Myers' "Celebrity Patient" Goes off Script









